Intellia Therapeutics Inc. Equity-NMS: NTLA

Healthcare

Biotechnology

Buy/Sell an entire stock
or a fraction.

Vested

Already an existing customer?

New User?

Open Your Free Demat Account And Start Trading Seamlessly

Loading, Please wait...

Error in Fetching Data, Please retry later.

No data available.

Previous close :

$65.6

52W high :

$180.59

1Y :

-57.81%

5Y :

290.1%

EPS(TTM): :

-5.36

Shares O/S :

76.01 M

Market cap :

5.15 B

What is the share price of Intellia Therapeutics Inc. today?

Intellia Therapeutics Inc. (NTLA) share price as of August 12, 2022, is $67.74. If you are investing from India, you can always check the valuation in the INR before investing.

Can Indian Investors purchase shares of Intellia Therapeutics Inc.?

Yes, Indian Investors can invest in the Intellia Therapeutics Inc. (NTLA) Share by opening an international trading account with Angel One.

How can I purchase Intellia Therapeutics Inc. shares in India?

Purchasing Intellia Therapeutics Inc. (NTLA) share from India can be done by:

Directly: By opening an international trading account with Angel One. The process would include KYC verification.
The account activation takes a few minutes to a few hours, after which you can start buying Intellia Therapeutics Inc. (NTLA) by making deposits in US dollars.
Indirectly: By investing in mutual funds and Exchange Traded Funds (ETF) that offers exposure in global stocks.

Can I buy Fractional shares of Intellia Therapeutics Inc.?

Yes, you can purchase fractional shares of Intellia Therapeutics Inc. (NTLA) or any other US company shares in Angel One for any dollar amount.

What is the market capitalization value of Intellia Therapeutics Inc.?

The market capitalization of Intellia Therapeutics Inc. on August 13, 2022, is $5.15 B.

In which sector Intellia Therapeutics Inc. belongs?

Intellia Therapeutics Inc. operates in the Healthcare sector, specifically in the Biotechnology industry.

What documents are required to invest in Intellia Therapeutics Inc. stocks?

In order to invest in Intellia Therapeutics Inc. (NTLA) you will need Proof of Identification (Aadhaar, PAN, Passport etc.) and Proof of Address (Aadhaar, Voter Card etc.)

From start to end, the process is digital and can be seamless.

Intellia Therapeutics, Inc. is a clinical-stage genome editing company. The Company is focused on developing curative therapeutics using Clustered, Regularly Interspaced Short Palindromic Repeats/CRISPR associated 9 (CRISPR/Cas9) technology. CRISPR/Cas9 is a technology for genome editing, the process of altering selected sequences of genomic deoxyribonucleic acid (DNA). It is focused on leveraging its modular platform to advance in vivo and ex vivo therapies for diseases with high unmet need. Its lead in vivo candidate, NTLA-2001, is for the treatment of transthyretin (ATTR) amyloidosis, as well as NTLA-2002 for the treatment of hereditary angioedema (HAE). The Company is developing ex vivo applications to address immuno-oncology and autoimmune diseases. Its advanced ex vivo programs include a wholly owned T cell receptor (TCR)-T cell candidate, NTLA-5001 for the treatment of acute myeloid leukemia (AML) and hematopoietic stem cells (HSCs) for the treatment of sickle cell disease.